A blood screening tool for detecting mild cognitive impairment and Alzheimer’s disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research.

Representation of Mexican Americans in Alzheimer’s disease (AD) clinical research has been extremely poor.